Delivery Order SPE2DB22D3016-SPE2DB25FARY1

Award Date 3/20/25
Potential Completion Date 3/21/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,594.81 firm fixed-price delivery order contract is for the supply of FEMRING 0.05 MG/DAY vaginal rings, with a completion date of February 12, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FEMRING 0.10 MG/DAY vaginal rings, with a ceiling value of $2,167.23 and a completion date of April 30, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,240.44, is for the delivery of FEMRING 0.05 MG/DAY VAG RINGS, a medical product. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,597.89, is for the supply of FEMRING 0.10 MG/DAY vaginal rings. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a $1,193.47 fixed-price delivery order awarded to the Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of FEMRING 0.05 MG/DAY vaginal rings to the U.S. government. The award was made by the Medical Supply Chain, a defense agency under the Defense Logistics Agency (DLA) Troop Support. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $2,098.70 under a broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, which runs through January 2025, is for the delivery of FEMRING 0.05 MG/DAY vaginal rings. This contract award is not designated as a set-aside and represents an open competition. Amerisourcebergen holds a $999,999,999 IDC with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,537.38 Firm Fixed Price Delivery Order contract is for the supply of FEMRING 0.05 MG/DAY VAG RINGS, a vaginal ring medication. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of FEMRING 0.10 MG/DAY VAG RINGS. The firm-fixed price delivery order, valued at $5,190.49, has a completion date of January 3, 2025. AmerisourceBergen Drug Corp, a for-profit pharmaceutical distributor, is the prime contractor and does not have any major subcontractors listed. The contract is not designated as a set-aside. AmerisourceBergen also holds a $999,999,999...
This federal contract award is a delivery order (SPE2DB22FT9W9) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of FEMRING 0.10 MG/DAY vaginal rings. The $1,647.15 fixed-price contract was awarded on June 30, 2022 by the Defense Logistics Agency (DLA), with an ultimate completion date of July 1, 2022. The contract is not designated under any set-aside program. Amerisourcebergen, a for-profit organization, is a key vendor for federal healthcare programs,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of FEMRING 0.10 MG/DAY vaginal rings. The award, valued at $3,128.46, is a firm fixed-price delivery order contract with an ultimate completion date of April 21, 2023. There was no set-aside designation for this contract. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company,...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FARY1
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FEMRING 0.05 MG/DAY vaginal rings, with a ceiling value of $3,550.09 and a performance period through March 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 6/21/25, 9:55 AM